Hospital Nacional Arzobispo Loayza
Lima, Peru
2 recruiting
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Study to Assess the Efficacy and Safety of Zipalertinib Versus Placebo for Adjuvant Treatment in Participants With Stage IB-IIIA NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection
Lung CancerEGFRNSCLC, Stage IB-IIIA+5 more
Taiho Oncology, Inc.360 enrolled253 locationsNCT07128199
Recruiting
Phase 3
A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)
Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
Hoffmann-La Roche1,050 enrolled351 locationsNCT06065748
Recruiting
Epidemiology and Processes of Care for Renal Replacement Therapy in Acute Kidney Injury in Latin America
renal replacement therapyAcute Kidney InjuryRenal Replacement Therapy for Acute Kidney Injury in ICU+3 more
University of Alabama at Birmingham1,000 enrolled15 locationsNCT07262320